CAPLIPOINT
Invest with MTF
Invest Now
Invest in Caplin Point Laboratories with 3.11X leverage
Caplin Point Laboratories live price: ₹1636. It opened at ₹1,650 vs previous close ₹1,662; intraday high/low: ₹1,662/₹1,625. The 50 & 200 DMA stand at ₹1,754.38/₹1,900.52.
Caplin Point Laboratories Performance
- Low
- ₹1,625
- High
- ₹1,662
- 52 Week Low
- ₹1,599
- 52 Week High
- ₹2,395
- Open Price₹1,650
- Previous Close₹1,662
- Volume81,182
- 50 DMA₹1,754.38
- 100 DMA₹1,831.36
- 200 DMA₹1,900.52
Investment Returns
- Over 1 Month -5.5%
- Over 3 Month -16.34%
- Over 6 Month -28.03%
- Over 1 Year -11.18%
Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!
Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.3
- PEG Ratio
- 1.1
- Market Cap Cr
- 12,436
- P/B Ratio
- 3.7
- Average True Range
- 43.35
- EPS
- 80.74
- Dividend Yield
- 0.4
- MACD Signal
- -29.99
- RSI
- 34.32
- MFI
- 26.83
Caplin Point Laboratories Financials
Caplin Point Laboratories Technicals
EMA & SMA
Current Price
₹1,636.00
-26.2
(-1.58%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,694.59
- 50 Day
- ₹1,754.38
- 100 Day
- ₹1,831.36
- 200 Day
- ₹1,900.52
Resistance and Support
1640.83
- R3 1,694.67
- R2 1,678.33
- R1 1,657.17
- S1 1,619.67
- S2 1,603.33
- S3 1,582.17
Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends
Caplin Point Laboratories F&O
About Caplin Point Laboratories
- NSE Symbol
- CAPLIPOINT
- BSE Symbol
- 524742
- Managing Director
- Dr. Sridhar Ganesan
- ISIN
- INE475E01026
Similar Stocks to Caplin Point Laboratories
Caplin Point Laboratories FAQs
Caplin Point Laboratories share price is ₹1,636 As on 17 March, 2026 | 06:44
The Market Cap of Caplin Point Laboratories is ₹12435.5 Cr As on 17 March, 2026 | 06:44
The P/E ratio of Caplin Point Laboratories is 20.3 As on 17 March, 2026 | 06:44
The PB ratio of Caplin Point Laboratories is 3.7 As on 17 March, 2026 | 06:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.